https://www.businesswire.com/news/home/20251007274842/en/AeroRx-Therapeutics-Announces-%2421-Million-Series-A-Financing-to-Advance-Inhaled-AERO-007-the-First-Nebulized-LABALAMA-for-COPD-into-Late-Stage-Clinical-Development
AeroRx Therapeutics Announces $21 Million Series A Financing to Advance Inhaled AERO-007, the First...
AeroRx Announces $21M Series A Financing to Advance Inhaled AERO-007, the First Nebulized LABA/LAMA for COPD, into Late-Stage Clinical Development
https://aerorxtx.com/
AeroRx Therapeutics: Nebulized Therapies for COPD | AeroRx Therapeutics is developing potential...
AeroRx Therapeutics is developing potential best-in-class nebulized combination therapies to improve COPD treatment.
therapeuticstherapiescopddevelopingpotential